MedCity News
Anthem, K Health, Blackstone launch digital health company
The new joint venture will bring K Health s artificial intelligence-driven technology to the consumer, employer and insurer markets. The solution enables patients to understand their symptoms and connect with a doctor if needed.
Shares0
Anthem has partnered with digital health startup K Health and funds managed by investment firm Blackstone to launch a technology-focused joint venture.
The financial terms of the venture launch were not disclosed.
Called Hydrogen Health, the joint venture will bring K Health’s artificial intelligence-driven technology to the consumer, employer and insurer markets, said K Health CEO Allon Bloch, in a phone interview. Bloch will also serve as CEO of Hydrogen Health.
Get the latest industry news first when you subscribe to our daily newsletter.
We will never sell or share your information without your consent. See our privacy policy.
Share /
at 9:15 AM
Promoted
In a podcast with MedCity News, Cho talked about the company’s profile in the San Diego life science ecosystem, the need to fail fast and frequently in the early stages of drug development and the work BMS is doing to combat Covid-19.
MedCity News
Cancer biotech Tango Therapeutics picks a SPAC as its IPO dance partner
Tango Therapeutics’ SPAC merger will infuse the biotech with $353 million to fund clinical trials for its cancer drugs based on synthetic lethality. Tango’s lead program is on track to reach the clinic next year.
Shares0
Tango Therapeutics hasn’t yet reached the clinic, but the company is on track bring its lead program there soon, and when it does it will be supported by $353 million from a merger deal that takes the company public.
Cambridge, Massachusetts-based Tango announced Wednesday that it has agreed to combine with BCTG Acquisition, a special purpose acquisition company (SPAC). Such publicly traded companies serve as vehicles for other private companies looking for a way to join the public markets other than a conventional IPO.
Get the latest industry news first when you subscribe to our daily newsletter.
We will never sell or share your information without your consent. See our privacy policy.